Correction: Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance

Read full text
Authors: Paulina Topa-Pila, Katheryne Y. Morales, Doménica P. Palacios-Mora, Cristina Flores-Hernández, Analía Altamirano-Cisneros, Joselyn Micaela Gavilanes, Keyla Villacís-López, Mirari Y. Arancibia, Johanna Mora-Domínguez, William Calero-Cáceres
Cited by: 2

Abstract

A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval.• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used.The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. 2026) Phage biobanks as enabling infrastructure for precision phage therapy in the era of antimicrobial resistance. Front. Antibiot. 5:1772871. doi: 10.3389/frabi.2026.1772871 Please also check that the initials used in the Author Contributions section or elsewhere in the article are correct.

Fields of Study & Subjects

Bacteriophages and microbial interactions Monoclonal and Polyclonal Antibodies Research vaccines and immunoinformatics approaches

Publication details

Journal / source
Frontiers in Antibiotics
Publisher
Frontiers Media SA
Volume
5
Pages
1804100–1804100
Publication date
11 February 2026
Language
EN